Oral application of bacterial lysate in infancy decreases the risk of atopic dermatitis in children with 1 atopic parent in a randomized, placebo-controlled trial. (Q52888937)
Jump to navigation
Jump to search
scientific article published in April 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Oral application of bacterial lysate in infancy decreases the risk of atopic dermatitis in children with 1 atopic parent in a randomized, placebo-controlled trial. |
scientific article published in April 2012 |
Statements
Oral application of bacterial lysate in infancy decreases the risk of atopic dermatitis in children with 1 atopic parent in a randomized, placebo-controlled trial. (English)
1 reference
1 reference
Ulrich Wahn
1 reference
Eckard Hamelmann
1 reference
Susanne Lau
1 reference
Kerstin Gerhold
1 reference
Kurt Zimmermann
1 reference
Siri Rossberg
1 reference
Petra Wagner
1 reference
Claudia Sulser
1 reference
Rita Bunikowski
1 reference
Imke Witt
1 reference
Juliane Wauer
1 reference
John Beschorner
1 reference
Georg Menke
1 reference
1 April 2012
1 reference
129
1 reference
1040-1047
1 reference
4
1 reference